Overview

Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure.

Status:
Completed
Trial end date:
2009-06-26
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of PF-04217329.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Latanoprost